Beam Therapeutics Inc (BEAM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BEAM? Forum Prognose

Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.33% 8.466	7.47	30.07	14.27	11.77
Operating Expenses	1.47% 128.62	126.76	130.10	120.77	116.67
Benefits Costs and Expenses	5.13% 110.76	116.74	120.42	110.94	102.78
Costs And Expenses	5.13% 110.76	116.74	120.42	110.94	102.78
Depreciation and Amortization	0.18% 5.538	5.528	-	-	-
Operating Income/Loss	0.73% -120.15	-119.29	-100.04	-106.50	-104.89
Nonoperating Income/Loss	78.31% 17.86	10.02	9.683	9.836	13.88
Income/Loss From Continuing Operations Before Tax	6.39% -102.29	-109.27	-90.35	-96.67	-91.01
Income Tax Expense/Benefit	-	-	-	-	0.039
Income/Loss From Continuing Operations After Tax	6.39% -102.29	-109.27	-90.35	-96.67	-91.05
Net Income/Loss	6.39% -102.29	-109.27	-90.35	-96.67	-91.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	15.94% 102.00	87.98	0.1716	82.41	82.31
Diluted Average Shares	15.94% 102.00	87.98	0.1716	82.41	82.31
Basic Earnings Per Share	19.35% -1.00	-1.24	-1.09	-1.17	-1.11
Diluted Earnings Per Share	19.35% -1.00	-1.24	-1.09	-1.17	-1.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$21.35

5.74%

INCY

$83.80

1.12%

GMAB

$31.81

0.13%

BNTX

$102.06

2.32%

INSM

$162.33

1.26%

ONC

$320.10

4.68%